Stimulatory action of cycloheximide on glucose metabolism in the rat epididymal fat pad. 1977

J A García-Sáinz, and E Piña, and V Chagoya de Sánchez

The action of cycloheximide on some parameters of glucose and lipid metabolism was studied in vitro in epidiymal fat pads from fasted rats. Incubation of fat pads with cycloheximide (1 mug/ml) for 2 hours resulted in a two-fold increase in glucose uptake, glucose oxidation, incorporation of glucose into lipids, and reesterification of free fatty acid. The increase in glucose oxidation was evident in experiments in which [U-14C], [1-14C], or [6-14C]glucose was added to the media, but it was absent when the media were supplemented with pyruvate. Incorporation of glucose into glycogen and accumulation of lactate in the medium were not seriously modified by the presence of cycloheximide. The stimulatory effect of cycloheximide on incorporation of glucose into lipids was absent when insulin or cortisol was added to the medium. A cycloheximide-mediated increase in glucose uptake seems to be responsible for the subsequent changes in glucose metabolism, and would seem to be independent of an inhibition in protein synthesis; puromycin and actinomycin D did not mimic the cycloheximide action on glucose incorporation into lipids.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008053 Lipid Mobilization LIPOLYSIS of stored LIPIDS in the ADIPOSE TISSUE to release FREE FATTY ACIDS. Mobilization of stored lipids is under the regulation of lipolytic signals (CATECHOLAMINES) or anti-lipolytic signals (INSULIN) via their actions on the hormone-sensitive LIPASE. This concept does not include lipid transport. Lipid Mobilizations,Mobilization, Lipid,Mobilizations, Lipid
D008297 Male Males
D011691 Puromycin A cinnamamido ADENOSINE found in STREPTOMYCES alboniger. It inhibits protein synthesis by binding to RNA. It is an antineoplastic and antitrypanosomal agent and is used in research as an inhibitor of protein synthesis. CL-13900,P-638,Puromycin Dihydrochloride,Puromycin Hydrochloride,Stylomycin,CL 13900,CL13900,P 638,P638
D003513 Cycloheximide Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. Actidione,Cicloheximide
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006003 Glycogen
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty

Related Publications

J A García-Sáinz, and E Piña, and V Chagoya de Sánchez
January 1962, Clinica chimica acta; international journal of clinical chemistry,
J A García-Sáinz, and E Piña, and V Chagoya de Sánchez
June 1987, Metabolism: clinical and experimental,
J A García-Sáinz, and E Piña, and V Chagoya de Sánchez
December 1986, Microscopia electronica y biologia celular : organo oficial de las Sociedades Latinoamericana de Microscopia Electronica e Iberoamericana de Biologia Celular,
J A García-Sáinz, and E Piña, and V Chagoya de Sánchez
November 1977, The Journal of nutrition,
J A García-Sáinz, and E Piña, and V Chagoya de Sánchez
July 1963, Metabolism: clinical and experimental,
J A García-Sáinz, and E Piña, and V Chagoya de Sánchez
January 1979, Journal of lipid research,
J A García-Sáinz, and E Piña, and V Chagoya de Sánchez
January 1976, Materia medica Polona. Polish journal of medicine and pharmacy,
J A García-Sáinz, and E Piña, and V Chagoya de Sánchez
July 1971, The Biochemical journal,
J A García-Sáinz, and E Piña, and V Chagoya de Sánchez
October 1962, The Journal of laboratory and clinical medicine,
J A García-Sáinz, and E Piña, and V Chagoya de Sánchez
April 1966, The Journal of biological chemistry,
Copied contents to your clipboard!